Li W - Search Results

1

Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease.

Wang W, LeBlanc ME, Chen X, Chen P, Ji Y, Brewer M, Tian H, Spring SR, Webster KA, Li W. Wang W, et al. Among authors: li w. Angiogenesis. 2017 Nov;20(4):479-492. doi: 10.1007/s10456-017-9557-6. Epub 2017 Apr 26. Angiogenesis. 2017. PMID: 28447229 Free PMC article.

2

Lyar Is a New Ligand for Retinal Pigment Epithelial Phagocytosis.

Guo F, Ding Y, Caberoy NB, Alvarado G, Liu R, Shen C, Yu J, Zhou Y, Salero E, LeBlanc ME, Wang W, Li W. Guo F, et al. Among authors: li w. J Cell Biochem. 2015 Oct;116(10):2177-87. doi: 10.1002/jcb.25089. J Cell Biochem. 2015. PMID: 25735755 Free PMC article.

3

Secretogranin III as a disease-associated ligand for antiangiogenic therapy of diabetic retinopathy.

LeBlanc ME, Wang W, Chen X, Caberoy NB, Guo F, Shen C, Ji Y, Tian H, Wang H, Chen R, Li W. LeBlanc ME, et al. Among authors: li w. J Exp Med. 2017 Apr 3;214(4):1029-1047. doi: 10.1084/jem.20161802. Epub 2017 Mar 22. J Exp Med. 2017. PMID: 28330905 Free PMC article.

4

Dendritic cell-derived exosomes for cancer immunotherapy: hope and challenges.

Tian H, Li W. Tian H, et al. Among authors: li w. Ann Transl Med. 2017 May;5(10):221. doi: 10.21037/atm.2017.02.23. Ann Transl Med. 2017. PMID: 28603736 Free PMC article. No abstract available.

5

Secretogranin III: a diabetic retinopathy-selective angiogenic factor.

Li W, Webster KA, LeBlanc ME, Tian H. Li W, et al. Cell Mol Life Sci. 2018 Feb;75(4):635-647. doi: 10.1007/s00018-017-2635-5. Epub 2017 Aug 30. Cell Mol Life Sci. 2018. PMID: 28856381 Free PMC article. Review.

6

Anti-secretogranin III therapy of oxygen-induced retinopathy with optimal safety.

Tang F, LeBlanc ME, Wang W, Liang D, Chen P, Chou TH, Tian H, Li W. Tang F, et al. Among authors: li w. Angiogenesis. 2019 Aug;22(3):369-382. doi: 10.1007/s10456-019-09662-4. Epub 2019 Jan 14. Angiogenesis. 2019. PMID: 30644010 Free PMC article.

7

Neurovascular regulation in diabetic retinopathy and emerging therapies.

Ji L, Tian H, Webster KA, Li W. Ji L, et al. Among authors: li w. Cell Mol Life Sci. 2021 Aug;78(16):5977-5985. doi: 10.1007/s00018-021-03893-9. Epub 2021 Jul 7. Cell Mol Life Sci. 2021. PMID: 34230991 Free PMC article. Review.

8

Selectively targeting disease-restricted secretogranin III to alleviate choroidal neovascularization.

Ji L, Waduge P, Hao L, Kaur A, Wan W, Wu Y, Tian H, Zhang J, Webster KA, Li W. Ji L, et al. Among authors: li w. FASEB J. 2022 Jan;36(1):e22106. doi: 10.1096/fj.202101085RR. FASEB J. 2022. PMID: 34918375 Free PMC article.

9

Secretogranin III stringently regulates pathological but not physiological angiogenesis in oxygen-induced retinopathy.

Dai C, Waduge P, Ji L, Huang C, He Y, Tian H, Zuniga-Sanchez E, Bhatt A, Pang IH, Su G, Webster KA, Li W. Dai C, et al. Among authors: li w. Cell Mol Life Sci. 2022 Jan 10;79(1):63. doi: 10.1007/s00018-021-04111-2. Cell Mol Life Sci. 2022. PMID: 35006382 Free PMC article.

10

Optimal Efficacy and Safety of Humanized Anti-Scg3 Antibody to Alleviate Oxygen-Induced Retinopathy.

He Y, Tian H, Dai C, Wen R, Li X, Webster KA, Li W. He Y, et al. Among authors: li w, li x. Int J Mol Sci. 2021 Dec 29;23(1):350. doi: 10.3390/ijms23010350. Int J Mol Sci. 2021. PMID: 35008775 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82,533 results

Search Page

Filters